STAT November 19, 2021
WASHINGTON — House Democrats Friday broke a monthslong logjam and advanced prescription drug pricing reform policies as part of a broader domestic spending package.
Despite a last-minute lobbying sprint by the pharmaceutical industry, the drug pricing deal Democrats announced earlier this month remained largely unchanged. The plan would allow Medicare to negotiate some drug prices, penalize drug makers that hike prices faster than inflation, and cap drug costs for seniors and patients who use insulin.
The package has several hurdles still to clear, as it has not yet passed the Senate, and if it’s changed, it will have to re-pass the House before landing on the president’s desk. The Senate also has a gauntlet of additional budgetary rules that policies...
Today's Sponsors
Today's Sponsor